We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Syneos Health Inc | NASDAQ:SYNH | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 42.98 | 42.96 | 42.99 | 0 | 01:00:00 |
During her tenure at Syneos Health Communications, she has been instrumental in developing award-winning communications programs and has helped integrate communications and commercial expertise into clinical development – unlocking innovative solutions to deliver life-saving therapies to patients worldwide.
“Our Syneos Health Communications team plays a fundamental role in our integrated operating model – helping us better understand patient, provider and policy maker needs and behaviors, to develop strategies to enable our customers’ success,” said Michael Brooks, Chief Operating Officer, Syneos Health. “With science evolving at a record pace, we are excited for Jeanine to take on her new role as President, continuing to advance innovative solutions, to drive growth and enterprise value.”
“Every day, Syneos Health Communications operates at the Heart of Health – helping customers predict what’s next and respond to the market’s demand for smarter and faster answers,” said Jeanine O’Kane, President, Syneos Health Communications. “For more than a decade, I’ve witnessed the forward-thinking, impactful work this portfolio of agencies designs and delivers for our customers. I look forward to driving strong momentum in this new role and I’m excited for what’s next.”
Syneos Heath Communications is known for its award-winning, insights-based communications programs that resonate emotionally, nurture motivation and accelerate customer success. Award winning agencies include Addison Whitney, Biosector 2, BoldSky Creative Studio, Cadent, Chamberlain Healthcare Public Relations, Chandler Chicco Agency, GSW, Litmus, Genicos and Spherico.
About Syneos HealthSyneos Health® (Nasdaq: SYNH) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.
We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics.
Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.
Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
Investor Relations Contact: | Press/Media Contact: |
Ronnie Speight | Gary Gatyas |
Senior Vice President, Investor Relations | Executive Director, External Communications |
+1 919 745 2745 | +1 908 763 3428 |
Investor.Relations@syneoshealth.com | gary.gatyas@syneoshealth.com |
1 Year Syneos Health Chart |
1 Month Syneos Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions